Stay updated on AK104 in NSCLC Phase II Clinical Trial
Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.

Latest updates to the AK104 in NSCLC Phase II Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page has updated the status from 'Recruiting' to 'Active, not recruiting' and has added a new date of '2025-03-12'.SummaryDifference3%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check45 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check52 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check74 days agoChange DetectedThe website has updated the intervention type to 'Verified 2022-03 by Akeso' and noted that the last known status is 'Recruiting', while the previous revision v2.13.3 has been removed.SummaryDifference2%
Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.